NovaBridge Biosciences (FRA:0VY)
Germany · Delayed Price · Currency is EUR 1.380
-0.020 (-1.43%)
Last updated: Jun 26, 2026, 8:03 AM CET
NovaBridge Biosciences Market Cap
NovaBridge Biosciences has a market cap or net worth of €166.3 million as of June 26, 2026. Its market cap has decreased by -11.92% in one year.
Market Cap
166.30M
Enterprise Value
-15.88M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
€1.38
Market Cap Chart
Since January 17, 2020, NovaBridge Biosciences's market cap has increased from 124.45M to 166.30M, an increase of 33.63%. That is a compound annual growth rate of 4.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 25, 2026 | 162.54M | -58.41% |
| Dec 31, 2025 | 390.81M | 484.53% |
| Dec 31, 2024 | 66.86M | -53.13% |
| Dec 29, 2023 | 142.66M | -56.11% |
| Dec 30, 2022 | 325.02M | -89.87% |
| Dec 31, 2021 | 3.21B | 18.02% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 17, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biotest GmbH & Co. KGaA | 1.31B |
| Darwin AG | 95.40M |
| 2invest AG | 44.96M |
| Biomark Diagnostics | 33.65M |
| Vidac Pharma Holding | 24.99M |
| co.don AG | 414.21K |
| Paion AG | 385.22K |
| bioXXmed AG | 222.93K |